Dudum Andrew

Dudum Andrew, chief executive officer of Hims & Hers Health (HIMS), has filed 63 Form 4 transactions with the SEC, all in the single company. The pattern is one-sided: total sell value reached $73.7 million, while buy value sat at zero. There were no open-market purchases, no acquisitions, and no recent buys. Every transaction in the filing history is a sale, an option exercise, a tax withholding, or a gift. The most recent activity, from August 2026, shows no open-market selling. Instead, the filings list a code "J" transaction on August 27, a gift on August 25, and a cluster of option exercises on August 14. Those exercises triggered a tax withholding of $2.2 million, which is an automatic disposition of shares to cover the exercise cost, not a discretionary sale. Similar patterns appear in June 2026, with option exercises and a $2.58 million tax withholding, and in March 2026, where exercises were paired with two withholdings totaling roughly $13 million. The largest single transaction in the recent window was a March 13, 2026, tax withholding of $10.8 million, which dwarfs the other withholdings. The only compensation grants, coded "A," occurred on March 11 and February 23, 2026, with no dollar value attached. The overall picture is that Dudum has not bought HIMS stock on the open market at any point in the filing history. His selling is concentrated in option exercises and the mandatory tax settlements that follow them, plus a few gifts. The $73.7 million in total sell value reflects those mechanics rather than a campaign of open-market disposals.